UK scientists developing new Ebola vaccine that could be ready in months
WHO says two experimental vaccines are being developed, but clinical trial doses could still be months away.
- On Wednesday, the World Health Organization declared the Ebola outbreak in the Democratic Republic of Congo and Uganda a public health emergency of international concern, with 51 confirmed cases spreading rapidly across the region.
- The current epidemic involves the rare Bundibugyo strain, which has caused only two previous outbreaks since 2007 and kills 30 to 50 per cent of those infected, presenting significant challenges for health authorities.
- Oxford Vaccine Group scientists are developing an experimental vaccine using Covid-19 technology, with animal testing underway and doses potentially available for clinical trials within two to three months.
- The United Nations released $60 million from its Central Emergency Response Fund to accelerate the regional response, while the United States pledged $23 million to fund up to 50 treatment clinics in affected areas.
- Although the WHO estimates vaccine development could take up to nine months, the vaccine has only been tested on rodents so far, leaving significant uncertainty about human effectiveness.
43 Articles
43 Articles
Recently, the World Health Organization (WHO) declared a Public Health Emergency of International Importance due to the outbreak of Ebola disease caused by the Bundibugyo virus in the Democratic Republic of the Congo and Uganda, a situation that has already ignited global health warnings due to the rapid spread and lack of approved vaccines that are specific to this new strain. According to the official report updated on 17 May 2026, WHO confirm…
Bundibugyo Ebola vaccines and treatments in development
Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo linked to the Bundibugyo strain of the virus.Unlike the more common Zaire strain, there are no approved vaccines or treatments for Bundibugyo. About 177 suspected deaths and almost 750 suspected cases have been reported in the outbreak, and the World Health Organization has warned the numbers are likely to…
Scientists at Oxford University are working on the development of a new Ebola vaccine to combat the rapidly spreading outbreak in the Democratic Republic of Congo, broadcast on Friday DPA and PA Media.
Oxford Mail
thisisoxfordshire.co.ukOxford scientists developing new Ebola vaccine to tackle outbreak
Oxford University scientists are rapidly developing a new Ebola vaccine to tackle an outbreak of the disease in the Democratic Republic of the Congo.
Coverage Details
Bias Distribution
- 38% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
